COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 184 filers reported holding COHERUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,275,056 | +19.9% | 1,944,967 | +36.9% | 0.00% | 0.0% |
Q2 2023 | $6,065,996 | -32.2% | 1,420,608 | +8.6% | 0.00% | 0.0% |
Q1 2023 | $8,949,250 | +89553.9% | 1,308,370 | +3.8% | 0.00% | 0.0% |
Q4 2022 | $9,982 | -99.9% | 1,260,420 | +2.5% | 0.00% | -50.0% |
Q3 2022 | $11,812,000 | +36.3% | 1,229,209 | +2.7% | 0.00% | +100.0% |
Q2 2022 | $8,665,000 | -42.5% | 1,196,852 | +2.5% | 0.00% | -50.0% |
Q1 2022 | $15,079,000 | -20.9% | 1,168,056 | -2.2% | 0.00% | 0.0% |
Q4 2021 | $19,068,000 | -0.9% | 1,194,760 | -0.3% | 0.00% | -33.3% |
Q3 2021 | $19,248,000 | +17.6% | 1,197,784 | +1.2% | 0.00% | +50.0% |
Q2 2021 | $16,368,000 | +1.9% | 1,183,568 | +7.7% | 0.00% | 0.0% |
Q1 2021 | $16,060,000 | -6.4% | 1,099,311 | +11.3% | 0.00% | -33.3% |
Q4 2020 | $17,162,000 | -2.3% | 987,470 | +3.1% | 0.00% | 0.0% |
Q3 2020 | $17,570,000 | +3.0% | 958,060 | +0.3% | 0.00% | -25.0% |
Q2 2020 | $17,055,000 | +8.5% | 954,959 | -1.4% | 0.00% | 0.0% |
Q1 2020 | $15,716,000 | -51.2% | 968,982 | -45.8% | 0.00% | +33.3% |
Q4 2019 | $32,198,000 | +85.5% | 1,788,292 | +108.8% | 0.00% | -25.0% |
Q3 2019 | $17,354,000 | -0.7% | 856,569 | +8.3% | 0.00% | 0.0% |
Q2 2019 | $17,480,000 | +83.9% | 790,963 | +13.5% | 0.00% | +100.0% |
Q1 2019 | $9,506,000 | -16.7% | 696,985 | -44.7% | 0.00% | 0.0% |
Q4 2018 | $11,410,000 | +8.8% | 1,260,950 | +98.3% | 0.00% | -33.3% |
Q3 2018 | $10,490,000 | +47.7% | 635,814 | +25.3% | 0.00% | +50.0% |
Q2 2018 | $7,103,000 | +47.3% | 507,425 | +16.3% | 0.00% | 0.0% |
Q1 2018 | $4,821,000 | +40.8% | 436,328 | +12.2% | 0.00% | +100.0% |
Q4 2017 | $3,423,000 | -32.4% | 389,013 | +2.5% | 0.00% | -50.0% |
Q3 2017 | $5,064,000 | +9.2% | 379,392 | +17.4% | 0.00% | 0.0% |
Q2 2017 | $4,636,000 | -19.6% | 323,126 | +18.5% | 0.00% | 0.0% |
Q1 2017 | $5,768,000 | -14.1% | 272,749 | +14.3% | 0.00% | -33.3% |
Q4 2016 | $6,716,000 | +16.1% | 238,610 | +10.4% | 0.00% | 0.0% |
Q3 2016 | $5,787,000 | +66.8% | 216,161 | +5.2% | 0.00% | +50.0% |
Q2 2016 | $3,470,000 | +60.7% | 205,465 | +102.0% | 0.00% | +100.0% |
Q1 2016 | $2,159,000 | +1.4% | 101,713 | +9.6% | 0.00% | 0.0% |
Q4 2015 | $2,130,000 | +18.8% | 92,778 | +3.7% | 0.00% | 0.0% |
Q3 2015 | $1,793,000 | -28.4% | 89,487 | +3.3% | 0.00% | 0.0% |
Q2 2015 | $2,503,000 | +32.9% | 86,616 | +40.6% | 0.00% | 0.0% |
Q1 2015 | $1,883,000 | +211.2% | 61,593 | +65.9% | 0.00% | – |
Q4 2014 | $605,000 | – | 37,127 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |